ICH Q12: Implementation Considerations for FDA-Regulated Products: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 20, 2021
September 10, 2021
2c7d4c33-4495-4c29-abb1-22058de23404
Related Documents
Standardization of Data and Documentation Practices for Product Tracing Guidance for Industry
Guidance DocumentMarch 2, 2018Center for Drug Evaluation and Research
Postapproval Manufacturing Changes to Biosimilar and Interchangeable Biosimilar Products Questions and Answers
Guidance DocumentJuly 23, 2024Center for Drug Evaluation and Research
Bridging for Drug-Device and Biologic-Device Combination Products: Draft Guidance for Industry
Guidance DocumentDecember 19, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox